Concepedia
Statistics
Publications
169
Citations
13.7K
H-Index
64
Active since
1972
Affiliations
Novartis (Switzerland)(Current)
Istituto Nazionale di Fisica Nucleare, Sezione di Padova
European Organization for Nuclear Research
Universität Hamburg
RWTH Aachen University
F. Gasparini is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.
Top concepts
MedicinePharmacologyNeuropharmacologyNeuroscienceNatural SciencesPhysicsParticle PhysicsSocial SciencesNeurochemistryEngineering
Publications per year
1972–2024
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr et al. · Neuropharmacology · 1999 · 720 citations
Biochemistry, Functional Selectivity, Medicine +7
Epigenetic Modification of the <i>FMR1</i> Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
Sébastien Jacquemont, Aurore Curie, Vincent des Portes et al. · Science Translational Medicine · 2011 · 610 citations
CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling Without Affecting Glutamate Binding
Stephane Litschig, F. Gasparini, D Rueegg et al. · Molecular Pharmacology · 1999 · 342 citations
Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
E Tatarczyńska, Aleksandra Kłodzińska, E Chojnacka-Wójcik et al. · British Journal of Pharmacology · 2001 · 308 citations · Full text
Observation of Sequential<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mi>Υ</mml:mi></mml:math>Suppression in PbPb Collisions
S. Chatrchyan, V. Khachatryan, A. M. Sirunyan et al. · Physical Review Letters · 2012 · 292 citations · Full text
1–5 of 169